The board of directors of China Grand Pharmaceutical and Healthcare Holdings Ltd. announced that on 29 March 2012, the Board has established a nomination committee. The members of the Nomination Committee shall comprise such directors of the company appointed by the Board. The Board has appointed Ms. So Tosi Wan, Winnie, Mr. Lo Kai Lawrence and Dr. Shao Yan, as members of the Nomination Committee and Ms. So Tosi Wan, Winnie has been appointed and shall act as the chairman of the Nomination Committee. The Board announced that in order to comply with the forthcoming amendments to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited which will take effect on 1 April 2012, Mr. Liu Chengwei will cease to act as the chairman of the remuneration committee of the Board but will remain as a member of the Remuneration Committee, and Ms. So Tosi Wan, Winnie, an independent non-executive Director and a member of the Remuneration Committee, has been appointed as the chairman of the Remuneration Committee both with effect from 29 March 2012.